Shree Jindal Proteins Profile
Key Indicators
- Authorised Capital ₹ 9.90 Cr
as on 13-12-2024
- Paid Up Capital ₹ 9.80 Cr
as on 13-12-2024
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 51.80 Cr
as on 13-12-2024
- Revenue -31.11%
(FY 2020)
- Profit -346.21%
(FY 2020)
- Ebitda -537.32%
(FY 2020)
- Net Worth -1.23%
(FY 2020)
- Total Assets -6.72%
(FY 2020)
About Shree Jindal Proteins
The Corporate was formerly known as Jindal Proteins Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.90 Cr and a paid-up capital of Rs 9.80 Cr.
The company has closed loans amounting to ₹51.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sat Jindal, Meena Kumari, Heena Aggarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U15310PB1997PLC019498
- Company No.
019498
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Feb 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Jindal Proteins?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sat Jindal  | Whole-Time Director | 26-Feb-1997 | Current |
| Meena Kumari | Director | 22-Mar-2011 | Current |
| Heena Aggarwal | Director | 22-Mar-2011 | Current |
| Sachin Goyal | Director | 01-Oct-2008 | Current |
Financial Performance of Shree Jindal Proteins.
Shree Jindal Proteins Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 31.11% decrease. The company also saw a substantial fall in profitability, with a 346.21% decrease in profit. The company's net worth dipped by a decrease of 1.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Jindal Proteins?
In 2020, Shree Jindal Proteins had a promoter holding of 52.21% and a public holding of 47.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Anand Enclave Developers Private LimitedActive 19 years 8 months
Sat Jindal and Sachin Goyal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 20 Dec 2010 | ₹33.80 Cr | Satisfied |
Punjab And Sind Bank Creation Date: 02 Aug 2008 | ₹11.50 Cr | Satisfied |
Syndicate Bank Creation Date: 08 Feb 2007 | ₹6.50 Cr | Satisfied |
How Many Employees Work at Shree Jindal Proteins?
Unlock and access historical data on people associated with Shree Jindal Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Jindal Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Jindal Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
